3 Factor Indexing’s Xylem XYL Stock Holding History

3 Factor Indexing’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$119	Sell	1 -1	-50%	-$115	﹤0.01%	371
2026 Q1	$239	Buy	+2	New	+$262	﹤0.01%	264

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

3 Factor Indexing's XYL Position: Q2 2026 in Review

3 Factor Indexing reduced its Xylem (XYL) stake by 50% in Q2 2026, selling an estimated $115 and leaving 1 share worth $119. The position accounts for ﹤0.01% of the portfolio, ranked #371.

3 Factor Indexing first reported a position in XYL in Q1 2026 and has held it in 2 quarters since. The position peaked at $239 in Q1 2026. 1,041 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

3 Factor Indexing held 1 share of Xylem worth $119 as of Q2 2026.
3 Factor Indexing sold 1 Xylem share in Q2 2026, an estimated $115.
Xylem made up ﹤0.01% of 3 Factor Indexing's portfolio in Q2 2026, its #371 holding.
3 Factor Indexing first reported a position in Xylem in Q1 2026 and has held it in 2 quarters since.
3 Factor Indexing's Xylem position peaked at $239 in Q1 2026.
1,041 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on 3 Factor Indexing's 13F filing for Q2 2026, filed 8 Jul 2026.